FrancisKimMD
Cardiology • Seattle, WAAdult Congenital Heart Disease
Associate Professor, Medicine, University of Washington School of Medicine
Are you Dr. Kim?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 29 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
Harborview Medical Center
325 9th Ave
Seattle, WA 98104Phone+1 206-744-8712
Summary
- Dr. Francis Kim, MD is a cardiologist in Seattle, Washington. He is currently licensed to practice medicine in Washington and California. He is affiliated with UW Medicine/Harborview Medical Center and UW Medicine/University of Washington Medical Center.
Education & Training
University of WashingtonResidency, Internal Medicine, 1991 - 1994
University of California (San Francisco)Residency, Internal Medicine, 1990 - 1991- University of California San Francisco School of MedicineClass of 1990
- University of WashingtonFellowship, Cardiovascular Disease
Certifications & Licensure
CA State Medical License 1991 - Present
WA State Medical License 1993 - 2025- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- Fellow (FACC) American College of Cardiology
Clinical Trials
- Pilot Community Clinical Study of Hypothermia in Cardiac Arrest Start of enrollment: 2004 Nov 01
- Induction of Mild Hypothermia Following Out-of-hospital Cardiac Arrest Start of enrollment: 2007 Dec 01
- Pilot Study of Sodium Nitrite in Resuscitated Cardiac Arrest Patients Start of enrollment: 2010 Jan 01
- Join now to see all
Publications & Presentations
PubMed
- 237 citationsFree Fatty Acid Impairment of Nitric Oxide Production in Endothelial Cells Is Mediated by IKKβFrancis Kim, Kelly A. Tysseling, Julie Rice, Matilda Pham, Lutfiyah Haji
Arteriosclerosis, Thrombosis, and Vascular Biology. 2005-05-01 - 35 citationsActivation of IKKβ by glucose is necessary and sufficient to impair insulin signaling and nitric oxide production in endothelial cellsFrancis Kim, Kelly A. Tysseling, Julie Rice, Byron Gallis, Lutfiyah Haji
Journal of Molecular and Cellular Cardiology. 2005-08-01 - 1 citationsDapagliflozin reduces systemic inflammation in patients with type 2 diabetes without known heart failure.Dennis D Wang, Anna V Naumova, Daniel Isquith, Jamie Sapp, Kim A Huynh
Cardiovascular Diabetology. 2024-06-07
Professional Memberships
- Member
